Study of the Benefits of Virtual Reality Headsets for Reducing Anxiety in Patients Treated for Pleural Effusion or Pneumothorax Using Small-bore Chest Drainage Tubes
eSEDATION
1 other identifier
interventional
38
1 country
1
Brief Summary
Pleural effusion and pneumothorax are common conditions encountered in pulmonology departments and may require chest drainage. However, the chest drainage procedure can cause anxiety in patients, leading to discomfort during the procedure. The use of virtual reality (VR) for anxiety reduction has shown promising results in various medical contexts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2025
CompletedFirst Posted
Study publicly available on registry
October 3, 2025
CompletedStudy Start
First participant enrolled
November 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
December 31, 2025
December 1, 2025
1.4 years
September 26, 2025
December 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain and Effects of personalized virtual reality
Compare the effects of personalized virtual reality support, compared to standard support, on pain in patients undergoing chest drainage with numerical pain scale from 0 to 10.
18 months
Anxiety and Effects of personalized virtual reality
Compare the effects of personalized virtual reality support, compared to standard support, on anxiety in patients undergoing chest drainage with numerical anxiety scale from 0 to 10.
18 months
Secondary Outcomes (4)
Pain assessment with or without VR headset based on heart rate
18 months
Pain assessment with or without VR headset based on respiratory rate
18 months
Patient satisfaction
18 months
Satisfaction of the paramedical team
18 months
Study Arms (2)
Reality virtual
EXPERIMENTALStandard support with reality virtual headset
Standard of care
NO INTERVENTIONStandard support without reality virtual headset
Interventions
Pleural effusion and pneumothorax will be drained with the patient wearing the virtual reality headset.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years;
- Patient requiring Sledinger thoracic drainage for pneumothorax or pleural effusion in the pulmonology department of Nice University Hospital;
- Patient affiliated with social security;
- Signature of informed consent.
You may not qualify if:
- Immediate emergency situations;
- Anxiolytic, antidepressant, or psychotropic treatment already in place;
- Cognitive, behavioral, or psychiatric disorders;
- Language barrier;
- History of chest drainage or chest surgery;
- Hearing disorders without hearing aids;
- Vision disorders without corrective lenses (lack of binocular vision, blindness);
- Psychotic patients or patients diagnosed with psychiatric disorders;
- History of epilepsy;
- Current migraine;
- Patients for whom three-dimensional films are contraindicated (pacemaker or defibrillator);
- No social security coverage;
- Patients under guardianship/curatorship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Nice - Hôpital Pasteur 2
Nice, Alpes-Maritimes, 06000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nelly BANSE
Centre Hospitalier Universitaire de Nice
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2025
First Posted
October 3, 2025
Study Start
November 27, 2025
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
December 31, 2025
Record last verified: 2025-12